Uh-oh! This study is no longer available.
Type 2 Diabetes (T2D) – Evaluating Doses of Ozempic®
Diabetes (Type 2 Diabetes)
PMG Research of Salisbury
18 or older
A research study is evaluating the effects of various doses of Ozempic® on glycemic control and body weight in adults with type 2 diabetes.
This research study may be an option if you:
• Have been diagnosed with T2D
• Have an HbA1c between 8 – 10%
• Are on a stable daily dose of metformin alone or in combination with sulfonylureas
• Do not have uncontrolled and potentially unstable diabetic retinopathy or maculopathy
Other criteria apply. Please make sure to discuss with a member of our research staff to ensure this research study is a good fit for you.
Qualified participants will receive all study-related care and Ozempic® (semaglutide) at no cost.
Patient Commitment Duration
Approximately 10 months
Financial compensation may be provided for time and travel expenses.
Number of visits in study
Approximately 9 clinic visits and 2 phone calls